Structure-Based Evolution of Subtype-Selective Neurotensin Receptor Ligands

Schaab C, Kling R, Einsiedel J, Hübner H, Clark T, Seebach D, Gmeiner P (2014)


Publication Language: English

Publication Type: Journal article, Original article

Publication year: 2014

Journal

Publisher: Wiley Open Access: Chemistry Open / Wiley

Book Volume: 3

Pages Range: 206-218

DOI: 10.1002/open.201402031

Abstract

Subtype-selective agonists of the neurotensin receptor NTS2 represent a promising option for the treatment of neuropathic pain, as NTS2 is involved in the mediation of m-opioid-independent anti-nociceptive effects. Based on the crystal structure of the subtype NTS1 and previous structure-activity relationships (SARs) indicating a potential role for the sub-pocket around Tyr11 of NT(8-13) in subtype-specific ligand recognition, we have developed new NTS2-selective ligands. Starting from NT(8-13), we replaced the tyrosine unit by β2-amino acids (type 1), by heterocyclic tyrosine bioisosteres (type 2) and peptoid analogues (type 3). We were able to evolve an asymmetric synthesis of a 5-substituted azaindolylalanine and its application as a bioisostere of tyrosine capable of enhancing NTS2 selectivity. The S-configured test compound 2a, [(S)-3-(pyrazolo[1,5-α]pyridine-5-yl)-propionyl11]NT(8-13), exhibits substantial NTS2 affinity (4.8 nm) and has a nearly 30-fold NTS2 selectivity over NTS1. The (R)-epimer 2b showed lower NTS2 affinity but more than 600-fold selectivity over NTS1.

Authors with CRIS profile

Additional Organisation(s)

Involved external institutions

How to cite

APA:

Schaab, C., Kling, R., Einsiedel, J., Hübner, H., Clark, T., Seebach, D., & Gmeiner, P. (2014). Structure-Based Evolution of Subtype-Selective Neurotensin Receptor Ligands. ChemistryOpen, 3, 206-218. https://dx.doi.org/10.1002/open.201402031

MLA:

Schaab, Carolin, et al. "Structure-Based Evolution of Subtype-Selective Neurotensin Receptor Ligands." ChemistryOpen 3 (2014): 206-218.

BibTeX: Download